Anavo Therapeutics is Drug Delivery in Netherlands that focus on phosphatase-driven disease business. Founded in 2020. They cover business area such as operator, systematically drug phosphatase, class therapeutic program, partnership, its platform, a rich pipeline, several indication, client, scientific expertise, phosphatase-drive disease biology and drug discovery, phosphatase-target allosteric modulator.
2020
( 4 years old in 2024 )
Phosphatase-driven Disease
-
JH Oortweg 19
2333 CH Leiden
Netherlands
Private
operatorsystematically drug phosphataseclass therapeutic programpartnershipits platforma rich pipelineseveral indicationclientscientific expertisephosphatase-drive disease biology and drug discoveryphosphatase-target allosteric modulator
* We use standard office opening hours in near Anavo Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Anavo Therapeutics is Drug Delivery business from Netherlands that founded in 2020 (4 years old in 2024), Anavo Therapeutics business is focusing on Phosphatase-driven Disease.
Anavo Therapeutics headquarter office and corporate office address is located in JH Oortweg 19 2333 CH Leiden Netherlands.
Anavo Therapeutics was founded in Netherlands.
In 2024, Anavo Therapeutics is currently focus on phosphatase-driven disease sector.
Above is snippet of Google Trends for "phosphatase-driven disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Anavo Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
